• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病中的侵蚀性关节炎和后葡萄膜炎:α干扰素和γ干扰素治疗

Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma.

作者信息

Kötter I, Dürk H, Eckstein A, Zierhut M, Fierlbeck G, Saal J G

机构信息

University Hospital, Department of Internal Medicine, Rheumatology/Clinical Immunology, Tübingen, Germany.

出版信息

Clin Exp Rheumatol. 1996 May-Jun;14(3):313-5.

PMID:8809448
Abstract

Very few patients with Behçet's disease (BD) have been treated with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) to date. We report the successful longterm treatment of a female German patient with erosive arthritis and posterior uveitis with IFN alpha and IFN gamma sequentially and in combination.

摘要

迄今为止,很少有白塞病(BD)患者接受过α干扰素(IFNα)或γ干扰素(IFNγ)治疗。我们报告了一名患有侵蚀性关节炎和后葡萄膜炎的德国女性患者,先后序贯及联合使用IFNα和IFNγ进行长期成功治疗的病例。

相似文献

1
Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma.白塞病中的侵蚀性关节炎和后葡萄膜炎:α干扰素和γ干扰素治疗
Clin Exp Rheumatol. 1996 May-Jun;14(3):313-5.
2
[The use of interferon alfa-2r in the treatment of autoimmune uveitis (primary or associated with Behçet's disease)].
Rev Clin Esp. 1996 May;196(5):293-8.
3
Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.聚乙二醇干扰素 α-2b 治疗 Behcet 葡萄膜炎的长期疗效:小病例系列。
Ocul Immunol Inflamm. 2019;27(1):15-22. doi: 10.1080/09273948.2017.1332768. Epub 2017 Jul 12.
4
Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease.
Rheumatology (Oxford). 2007 Oct;46(10):1570-3. doi: 10.1093/rheumatology/kem199. Epub 2007 Aug 16.
5
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.干扰素α-2a治疗白塞病难治性葡萄膜炎的临床经验
Yonsei Med J. 2015 Jul;56(4):1158-62. doi: 10.3349/ymj.2015.56.4.1158.
6
[Ocular manifestations in Behçet's disease].[白塞病的眼部表现]
Rev Med Interne. 2014 Feb;35(2):97-102. doi: 10.1016/j.revmed.2013.10.011. Epub 2013 Nov 27.
7
Treatment of Adamantiades-Behçet disease with systemic interferon alfa.
Arch Dermatol. 1998 Aug;134(8):1010-6. doi: 10.1001/archderm.134.8.1010.
8
Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.α干扰素治疗难治性及威胁视力的葡萄膜炎的疗效:一项对45例患者的回顾性单中心研究
Br J Ophthalmol. 2007 Mar;91(3):335-9. doi: 10.1136/bjo.2006.101550. Epub 2006 Oct 18.
9
Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.接受重组人干扰素α-2a治疗的白塞病葡萄膜炎患者中的抗干扰素α抗体和自身抗体。
Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):457-65. doi: 10.1007/s00417-014-2856-3. Epub 2014 Dec 12.
10
[Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients].[白塞病:葡萄膜炎——α2a干扰素治疗——33例患者的前瞻性临床研究]
Klin Monbl Augenheilkd. 2001 Dec;218(12):768-73. doi: 10.1055/s-2001-19687.

引用本文的文献

1
Erosive wrist and hand arthritis: is it a rare manifestation of Behçet's disease?侵蚀性腕关节炎和手关节炎:是贝赫切特病的罕见表现吗?
Rheumatol Int. 2013 Oct;33(10):2703-5. doi: 10.1007/s00296-012-2498-x. Epub 2012 Aug 1.
2
Erosive arthritis in a patient with Behçet's disease.白塞病患者的侵蚀性关节炎。
Rheumatol Int. 2003 Sep;23(5):265-7. doi: 10.1007/s00296-003-0302-7. Epub 2003 Jul 16.
3
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.人重组干扰素α-2a用于治疗伴有威胁视力的后部或全葡萄膜炎的白塞病。
Br J Ophthalmol. 2003 Apr;87(4):423-31. doi: 10.1136/bjo.87.4.423.
4
Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.用干扰素α2a治疗白塞病眼部症状:一项试点研究。
Br J Ophthalmol. 1998 May;82(5):488-94. doi: 10.1136/bjo.82.5.488.